A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions

Clinical trial NCT07421375 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07421375
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2026-04-02
Primary completion: 2026-05-31
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.